Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03296657 · ClinicalTrials.gov registry record · NA
Analysis of Stannous Fluoride in GCF and Subgingival Plaque
A NA study of Subgingival Plaque and GCF, sponsored by Procter and Gamble.
- Completed
- Registry status
- NA
- Development phase
- 20
- Enrollment target
- 1
- Study location
NCT03296657: Completed NA study of Subgingival Plaque and GCF, sponsored by Procter and Gamble.
NCT03296657 is a NA study of Subgingival Plaque and GCF that has completed, run by Procter and Gamble. The registered enrollment target is 20 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (99% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03296657, a NA study of Subgingival Plaque and GCF, has completed, sponsored by Procter and Gamble.
- COMPLETED
- Registry status
- NA
- Development phase
- 20 participants
- Enrollment target
- 1
- Study location
Study Summary
The amount of stannous fluoride in GCF and subgingival plaque samples will be analyzed.
Primary Outcome
per GCF sample amount of stannous level in ng/uL will be measured
Conditions Studied
Interventions
- DRUG stannous fluoride
Study Locations (1)
Indiana
- Salus Research - Fort Wayne
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 20 participants |
| Start Date | 2017-08-23 |
| Est. Completion | 2017-09-22 |
| Phase | NA |
What the finished NCT03296657 record still lists
NCT03296657 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 20 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (99% lower).
The record links to 2 conditions, with Subgingival Plaque appearing as the primary indexed condition, and to 1 intervention - of which stannous fluoride is the first listed.
NCT03296657 reports a single indexed study location in Indiana.
Frequently Asked Questions
What is clinical trial NCT03296657 about?
NCT03296657 is a clinical study titled "Analysis of Stannous Fluoride in GCF and Subgingival Plaque". The amount of stannous fluoride in GCF and subgingival plaque samples will be analyzed.
What is the current status of trial NCT03296657?
This trial is currently completed. It is a NA study. The enrollment target is 20 participants. The study started on 2017-08-23. Estimated completion is 2017-09-22.
What conditions does trial NCT03296657 study?
This clinical trial studies the following conditions: Subgingival Plaque, GCF.
What interventions are being tested in trial NCT03296657?
The interventions under investigation include: stannous fluoride (DRUG).
Who is sponsoring clinical trial NCT03296657?
This trial is sponsored by Procter and Gamble, which has 70 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT03296657 being conducted?
This trial has 1 study location across Indiana. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT03296657's enrollment target sits among peer trials
20 1768th of 2000 higher than 140 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00573339 · 20 participants
Cardiac Magnetic Resonance Imaging (MRI) Normal Reference Control Group Testing
- NCT00692939 · 20 participants · Phase 1
Autologous Stem Cell Transplantation for Crohn's Disease
- NCT00967785 · 20 participants · Phase 1
A Phase I Study of Mozobil in the Treatment of Patients With WHIMS
- NCT01406691 · 20 participants · Phase 4
Light Flashes to Treat Delayed Sleep Phase Disorder (DSPD)
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI